- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06204510
Effects of Complex Decongestive Therapy on Proprioception, Balance and Tactile Sense
March 22, 2024 updated by: Emine Cihan, Selcuk University
Effects of Complex Decongestive Therapy on Proprioception, Balance and Tactile Sense in Lymphedema After Cancer Surgery: A Prospective Randomized Controlled Study
The aim of this study is to investigate the effects of complex decongestive physiotherapy (CDP) on propriseception, balance and sensation in patients with secondary lymphedema that develops in the lower extremities after cancer surgery.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Emine Cihan, PhD
- Phone Number: +90 5548928407
- Email: pteminecihan@gmail.com
Study Locations
-
-
-
Konya, Turkey, 42130
- Recruiting
- Selcuk University
-
Contact:
- Emine Cihan, pHd
- Phone Number: +90 5548920407
- Email: pteminecihan@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Being between the ages of 18-65
- Having unilateral lymphedema in the lower extremity secondary to cancer surgery
Exclusion Criteria:
- Having bilateral lower extremity lymphedema
- Having an active infection
- Having a mental cognitive disorder
- Being at a level where communication and cooperation cannot be established
- Situations where manual lymphatic drainage is contraindicated (such as severe heart failure and/or uncontrolled rhythm disorder, uncontrolled hypertension, pregnancy, presence of thrombus, active infection)
- Presence of metastasis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: control group
|
|
|
Experimental: study group
|
This application consists of manual lymph drainage, skin care, compression bandage and exercises.
This phase will continue for 3 weeks, 5 days a week.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of Proprioception
Time Frame: 10 minutes
|
Joint position sense: While the patient lies in the prone position, 15-45-60 degrees of knee flexion will be evaluated in 2 different ways: eyes open and eyes closed.
Participants will be asked to find the target angle they have been taught with their eyes closed and will be asked to say "here" in the position where they think they have reached the target angle.
|
10 minutes
|
|
One-leg Standing Test
Time Frame: 5 minutes
|
It is performed with one leg supported to evaluate static balance.
The eyes will be fixed in the direction of the head and the participant will be asked to close their eyes and will be expected to maintain balance for 30 seconds.
It ends when the balance is disrupted.
The test will be terminated when the maximum time of 30 seconds expires.
|
5 minutes
|
|
30 Seconds Sit-Stand-on-Chair Test:
Time Frame: 5 minutes
|
In the application of the test, the participant will be asked to sit in the middle part of a 43.18 cm (12 inches) high chair with his back upright, his feet on the ground and his arms crossed in front of his body.
While in this position, the test started with the "start" command and the participant will be asked to stand up and sit down as fully as he can for 30 seconds.
Standing upright once will count as 1, and the number of times he stands upright during 30 seconds will constitute the participant's score
|
5 minutes
|
|
Softt Touch Sense
Time Frame: 5 minutes
|
It is evaluated with Semmes Weinstein Monofilaments (SWM).
The test will be performed with the patient lying in the supine position.
In practice, the areas to be tested will be determined as the 1st metatarsal and 5th metatarsal heads and the midpoint of the heel.
Values between 1.65-2.83
(green) are considered normal sensation.
Values between 3.22-3.61
(blue) are reduced light touch, values between 3.84-4.31
(purple) are reduced protective sensation, values between 4.56-6.65 (red) are loss of protective sensation and 6, If there is no response to 65, it is considered deep pressure perception.
|
5 minutes
|
|
Two Point Discrimination
Time Frame: 5 minutes
|
Participants will be evaluated in a sitting position with eyes closed using an aesthesiometer (Instrument Company, Lafayette, IN, USA).
The evaluation will be made from the trans-metatarsal area, the middle of the foot and the middle of the heel.
It will start from the range where the two points can be easily distinguished.
The shortest length felt between two points will give the static two-point discrimination value.
|
5 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2024
Primary Completion (Actual)
March 15, 2024
Study Completion (Estimated)
April 12, 2024
Study Registration Dates
First Submitted
January 3, 2024
First Submitted That Met QC Criteria
January 3, 2024
First Posted (Actual)
January 12, 2024
Study Record Updates
Last Update Posted (Actual)
March 25, 2024
Last Update Submitted That Met QC Criteria
March 22, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023/03.01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Therapy-Associated Cancer
-
Centre Hospitalier de PerigueuxUniversity Hospital, LimogesRecruitingTherapy-Associated CancerFrance
-
Karadeniz Technical UniversityCompletedHappiness | Therapy-Associated Cancer | Symptoms | Cancer PatientTurkey
-
The Hospital for Sick ChildrenCompletedTherapy-Associated CancerCanada
-
The Hospital for Sick ChildrenCompletedTherapy-Associated Cancer
-
Huazhong University of Science and TechnologyUnknownNeoplasms, Therapy-AssociatedChina
-
Nanjing First Hospital, Nanjing Medical UniversityNot yet recruitingHelicobacter Pylori Infection | High-dose Dual Therapy | Metabolic-associated Steatohepatitis | Huazhi Rougan Granule
-
CHA UniversityEnrolling by invitationCancer | Psychological Distress | Cancer Pain | Distress, Emotional | Therapy-Associated Cancer | Psychiatric or Mood Diseases or ConditionsKorea, Republic of
-
Selcuk UniversityEnrolling by invitationCancer | Neuropathy | Therapy-Associated CancerTurkey
-
Chinese SLE Treatment And Research GroupThe First Affiliated Hospital of Anhui Medical University; Shanghai Zhongshan... and other collaboratorsRecruitingANCA Associated Vasculitis | Maintenance TherapyChina
-
Masonic Cancer Center, University of MinnesotaActive, not recruitingCancer | HPV Associated CancerUnited States
Clinical Trials on complex decongestive therapy
-
Fundacion Universitaria Maria CanoCompletedBreast Cancer LymphedemaColombia
-
Marmara UniversityUnknown
-
Medipol UniversityCompletedQuality of Life | Lymphedema | Edema | Urine MarkingTurkey
-
Bakirkoy Dr. Sadi Konuk Research and Training HospitalCompleted
-
Ankara Yildirim Beyazıt UniversityNot yet recruiting
-
Marmara UniversityUnknownLymphedema of Upper ArmTurkey
-
South Valley UniversityRecruiting
-
Gaziler Physical Medicine and Rehabilitation Education...RecruitingLymphedema | Physical Rehabilitation | Gait Dysfunction | Chronic EdemaTurkey (Türkiye)
-
Kirsehir Ahi Evran UniversitesiRecruitingLymphedema, Breast CancerTurkey